Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Lack of germline CDK6 mutations in familial melanoma

Abstract

Germline mutations in genes encoding several components of the retinoblastoma pathway have been linked with inherited predisposition to melanoma. Most commonly, such mutations involve CDKN2A, a cyclin-dependant kinase inhibitor of two kinases, CDK4 and CDK6, which phosphorylate the retinoblastoma protein (pRB) and thereby promote passage through the G1/S cell-cycle restriction point. Less frequently, germline mutations in the CDK4 gene have also been linked with an increased risk of melanoma. Despite the sequence and functional homology between CDK4 and CDK6, the role of germline mutations in CDK6 in melanoma predisposition is unknown. We detected no CDK6 mutations within the p16 (CDKN2A) binding domain in index cases from 60 melanoma-prone kindreds that lacked germline mutations in the coding regions of either CDKN2A or within the entire CDK4 coding region. We conclude that germline mutations in CDK6 do not make a significant contribution to melanoma predisposition.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Bataille V, Hiles R and Bishop JA . 1995 Br J Dermatol 132: 134–138

  • Brotherton DH, Dhanaraj V, Wick S, Brizuela L, Domaille PJ, Volyanik E, Xu X, Parisini E, Smith BO, Archer SJ, Serrano M, Brenner SL, Blundell TL and Laue ED . 1998 Nature 395: 244–250

  • Byeon I-JL, Li J, Ericson K, Selby TL, Tevelev A, Kim H-J, O'Maille P and Tsai M-D . 1998 Mol Cell Biol 18: 421–431

  • Ceha HM, Nasser I, Medema RH and Slebos RJC . 1998 Biochem Biophys Res Commun 249: 550–555

  • Coleman KG, Wautlet BS, Morrisseys D, Mulheron J, Sedman SA, Brinkley P, Price S and Webster KR . 1997 J Biol Chem 272: 18869–18874

  • Dracopoli NC and Fountain JW . 1996 Cancer Surv 26: 115–132

  • Draper GJ, Sanders BM and Kingston JE . 1986 Br J Cancer 53: 661–671

  • Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N and Boice Jr JD . 1993 J Natl Cancer Inst 85: 1121–1128

  • FitzGerald MG, Harkin DP, Silva-Arieta S, MacDonald DJ, Lucchina LC, Unsal H, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ and Haber DA . 1996 Proc Natl Acad Sci USA 93: 8541–8545

  • Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC . 1994 Nature Genet 8: 15–21

  • Kato J, Matsushime H, Hiebert S, Ewen ME and Sherr CJ . 1993 Genes Dev 7: 331–342

  • Liu L, Lassam NJ, Slingerland JM, Bailey D, Jenkins R and Hogg D . 1995 Oncogene 11: 405–412

  • Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N and Hogg D . 1999 Nature Genet 21: 128–132

  • Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine ARC, Xu X, Brizuela L, Brenner SL and Laue ED . 1997 Nature 389: 999–1003

  • Miller SA, Dykes DD and Polesky HF . 1988 Nucleic Acids Res 16: 1215

  • Ruas M and Peters G . 1998 Biochem Biophys Acta 1378: F115–F177

  • Russo AA, Tong L, Lee J-O, Jeffrey PD and Pavletich NP . 1998 Nature 395: 237–243

  • Serrano M, Hannon GJ and Beach D . 1993 Nature 366: 704–707

  • Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, the French Familial Melanoma Study Group, Benard J and Bressac-de Paillerets B . 1998 Hum Mol Gen 7: 209–216

  • Traboulsi EI, Zimmerman LE and Manz HJ . 1988 Arch Ophthamol 106: 1059–1061

  • Tucker MA and Goldstein AM . 1995 Dermatol Clin 13: 605–612

  • Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK and Fountain JW . 1995 Hum Mol Genet 4: 1845–1852

  • Weinberg RA . 1995 Cell 8: 323–329

  • Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N and Dracopoli NC . 1996 Nature Genet 12: 97–99

Download references

Acknowledgements

This work was supported by grants from the National Cancer Institute of Canada.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shennan, M., Badin, AC., Walsh, S. et al. Lack of germline CDK6 mutations in familial melanoma. Oncogene 19, 1849–1852 (2000). https://doi.org/10.1038/sj.onc.1203507

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203507

Keywords

This article is cited by

Search

Quick links